Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 557

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

A CRISPR/Cas12a-empowered surface plasmon resonance platform for rapid and specific diagnosis of the Omicron variant of SARS-CoV-2

Open access
Chen, Zhi, Li, Jingfeng, Li, Tianzhong, Fan, Taojian, Meng, Changle, Li, Chaozhou, Kang, Jianlong, Chai, Luxiao, Hao, Yabin, Tang, Yuxuan, Al-Hartomy, Omar A, Wageh, Swelm, Al-Sehemi, Abdullah G, Luo, Zhiguang, Yu, Jiangtian, Shao, Yonghong, Li, Defa, Feng, Shuai, Liu, William J, He, Yaqing, Ma, Xiaopeng, Xie, Zhongjian, Zhang, Han·2022·National Science Review

Abstract

The outbreak of the COVID-19 pandemic was partially due to the challenge of identifying asymptomatic and presymptomatic carriers of the virus, and thus highlights a strong motivation for diagnostics with high sensitivity that can be rapidly deployed. On the other hand, several concerning SARS-CoV-2 variants, including Omicron, are required to be identified as soon as the samples are identified as ‘positive’. Unfortunately, a traditional PCR test does not allow their specific identification. Herein, for the first time, we have developed MOPCS (Methodologies of Photonic CRISPR Sensing), which combines an optical sensing technology-surface plasmon resonance (SPR) with the ‘gene scissors’ clustered regularly interspaced short palindromic repeat (CRISPR) technique to achieve both high sensitivity and specificity when it comes to measurement of viral variants. MOPCS is a low-cost, CRISPR/Cas12a-system-empowered SPR gene-detecting platform that can analyze viral RNA, without the need for amplification, within 38 min from sample input to results output, and achieve a limit of detection of 15 fM. MOPCS achieves a highly sensitive analysis of SARS-CoV-2, and mutations appear in variants B.1.617.2 (Delta), B.1.1.529 (Omicron) and BA.1 (a subtype of Omicron). This platform was also used to analyze some recently collected patient samples from a local outbreak in China, identified by the Centers for Disease Control and Prevention. This innovative CRISPR-empowered SPR platform will further contribute to the fast, sensitive and accurate detection of target nucleic acid sequences with single-base mutations.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/nsr/nwac104

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 39 references

Cited by

See all 557

Metadata

Authors
Chen, Z., Li, J., Li, T., Fan, T., Meng, C., Li, C., Kang, J., Chai, L., Hao, Y., Tang, Y., Al-Hartomy, O. A., Wageh, S., Al-Sehemi, A. G., Luo, Z., Yu, J., Shao, Y., Li, D., Feng, S., Liu, W. J., He, Y., Ma, X., Xie, Z., & Zhang, H.
Venue
National Science Review
Published
2022-06-03
Volume
9
Issue
8
Pages
nwac104-nwac104
ISSN
  • 2053-714X (ISSN-L)
  • 2095-5138
OpenAlex
W4282004200
Cited by
557
References
39
FWCI
44.00
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A CRISPR/Cas12a-empowered surface plasmon resonance platform for rapid and specific diagnosis of the Omicron variant of SARS-CoV-2. https://app.cochat.ai/papers/10.1093/nsr/nwac104
The paper
Chen, Z., Li, J., Li, T., Fan, T., Meng, C., Li, C., Kang, J., Chai, L., Hao, Y., Tang, Y., Al-Hartomy, O. A., Wageh, S., Al-Sehemi, A. G., Luo, Z., Yu, J., Shao, Y., Li, D., Feng, S., Liu, W. J., . . . Zhang, H. (2022). A CRISPR/Cas12a-empowered surface plasmon resonance platform for rapid and specific diagnosis of the Omicron variant of SARS-CoV-2. National Science Review. https://doi.org/10.1093/nsr/nwac104

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.